Introductory Statement
Diet-induced obesity is an epidemic that predisposes individuals to cardiometabolic complications, including type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD), which are conditions directly related to inappropriate ectopic lipid deposition, fatty deformation, and altered hepatic lipid metabolism. NAFLD refers to hepatic steatosis, or the accumulation of lipid in the liver, not related to alcohol consumption (1) . The prevalence of NAFLD has been reported to be as high as 30% in western countries (2) . NAFLD prevalence is directly correlated with obesity and insulin resistance. As such, current trends in obesity and diabetes epidemiology predict an increased incidence of NAFLD worldwide. NAFLD includes a broad spectrum of diseases from simple hepatic steatosis to inflammatory steatohepatitis with increasing levels of fibrosis and ultimately cirrhosis (3) .
. The pathogenesis of NAFLD and its progression to fibrosis and chronic liver disease are still unknown. A popular "two-hit" hypothesis has been proposed in which the first hit is an initial metabolic alteration, such as insulin resistance, hyperglycemia, and the accumulation of triglyceride in hepatocytes, leading to hepatic steatosis. The second hit induces the progression to more severe injury including steatohepatitis, inflammation, fibrosis, and cirrhosis (4).
These excesses lead to adipogenesis and adipocyte differentiation in both subcutaneous and visceral areas and tissue, which have been shown to disturb regulation of lipid protein signalers such as cytokines, chemokines, and adipocytokines, resulting in impaired lipid signaling, lipid metabolism and systemic inflammation. Altered lipid metabolism in particular occurs through factors that are linked to adipose tissue, such as free fatty acids, leading to a hindered metabolic state via increased hepatic insulin resistance and fat accumulation in the liver.
Currently, the principal therapeutic modalities for NAFLD are lifestyle interventions (5), while pharmacologic treatments used for improving hepatic inflammation, fibrosis, and clearing steatohepatitis offer limited results (6) . Recent evidence indicates that activation of Transient Receptor Potential Vanilloid 1 (TRPV1) cation channels by its agonist, capsaicin, is beneficial for the management of obesity, diabetes and related diseases. TRPV1, a polymodal cation channel, has been found to be expressed ubiquitously. Human and animal studies support a requisite role for TRPV1 and capsaicin to regulate energy expenditure and metabolism, reduce adipose tissue weight and increase lipid oxidation (7) . Similarly, TRPV1 has also been shown to regulate adipocyte function through the utilization of calcitonin gene-related peptide (CGRP)-dependent mechanism, to thus prevent preadipocyte differentiation (8, 9) . As such, capsaicin and TRPV1 could potentially be a useful strategy to combat diet-induced obesity and cardiometabolic diseases such as NAFLD.
A role for TRPV1 in the physiology and pathophysiology of liver function is beginning to be elucidated, but there is much more that remains to be understood. For instance, TRPV1 activation has been shown to modulate the inflammatory responses and fatty acid oxidation in the liver (10). Li et al., 2012 demonstrated that TRPV1 activation leads to increased hepatic uncoupling protein 2 (UCP2), to elicit a reduction in fatty acid content in the hepatocyte mitochondrial matrix and thus an overall decrease in hepatic fatty deposition (11) . In this way, it is evident that TRPV1 improves hepatic health and prevents NAFLD, yet the specific mechanistic roles of TRPV1 in the liver are still unknown. In the current study, we present experimental evidence that loss of TRPV1 channels contributes to diet-induced obesity and the development of T2DM and NAFLD in mice fed a high fat/sugar diet for 24 weeks.
Experimental Procedures

Animal Models
All procedures were conducted with the approval of the Institutional Animal Care and production were calculated and recorded electronically over 24 hours for each mouse (following a 48-hour acclimation period).
Metabolic Assessment
Weekly diet consumption and body weight were recorded in all mice. In conjunction, 
Hepatic Lipid Extraction and Histology
Lipid extraction from liver was performed as described (12) . Extracted TG and cholesterol contents were normalized to wet liver weight. Commercially available assays were utilized to measure the concentration of triglycerides (Infinity, ThermoFisher), cholesterol (Infinity) and free fatty acids (Wako Diagnostics, Richmond, VA) in liver tissue and serum. 100 mg liver samples were homogenized and lipids were isolated using a 7:10:0.1 ratio of chloroform:isopropanol:NP-40. Serum was prepared after centrifugation of whole blood at 12,000 g for 10 min. For histology, livers collected from mice were embedded in Tissue-Tek OCT compound. After sectioning, samples were stained with hematoxylin and eosin (H&E) or Oil Red O for microscopic observation.
The sections were visualized under an Olympus upright microscope fitted with a SPOTimaging camera. The images were then enhanced and color corrected using Autodesk Pixlr Editor.
Results
V1KO mice are susceptible to diet-induced phenotypic changes
At 5 weeks of age, mice exhibited no differences in body weights or lean mass to body weight ratios (LM/BW) between groups. Wild type and V1KO mice exhibited normal weight gain and growth on the control diet. Interestingly, both male and female V1KO mice on the western diet exhibited a significant increase in body weight over the 24-week period, in contrast to male and female WT mice fed the western diet ( Fig. 1A and 1B). Male V1KO mice displayed a notable increase in central white fat normalized to BW compared to their WT counterparts regardless of diet, yet this effect was more pronounced following diet-induced obesity (Fig. 1C) . In contrast, female V1KO mice only exhibited an increase in central adiposity following the western diet regimen (Fig.   1D ). Using Echo MRI, lean mass to body weight compositions were collected at 5 and 29 weeks of age. No differences in lean mass to body weight ratio were observed between wild-type and knockout mice at baseline. However, after 24 weeks of dietinduced obesity, both WT and knockout mice exhibited a significant decrease in this ratio, which was further exacerbated in V1KO animals ( Fig. 1E ). This decrease in LM/BW correlated with an increase in overall fat mass (Fig. 1F ). The differences in these observations between sexes indicate that female V1KO mice are comparable to wild-type mice on a normal diet, while male V1KO mice are pre-dispositioned to dysfunction without Western diet.
V1KO mice exhibit severe glucose intolerance after Western diet regimen
To examine if diet-induced obesity is associated with altered glucose homeostasis, differences in fasted glucose levels and glucose handling (as measured by GTT) were measured in all groups at 5 and 29 weeks of age. At 5 weeks of age, fasting glucose levels showed no difference between groups. Following completion of the 24-week diet regiment, both male and female western diet fed V1KO mice exhibited a significant increase in fasted glucose compared to their WT counterparts ( Fig. 2A and 2B ). To further assess glucose handling, GTTs were performed in 29 week mice feed chow or western diet. Regardless of diet, both male and female V1KO mice exhibited glucose intolerance, while only the western diet fed WT mice exhibited this intolerance ( Fig. 2C and 2D).
Using CLAMS metabolic assessment, RER was determined in mice at 5 weeks and following 24 weeks of diet. At 5 weeks, RER was significantly increased in knockout male mice compared to male WT counterparts (Fig. 3A) . Following 24 weeks of high fat diet, RER was significantly decreased in both male groups compared to their counterparts, which were fed standard chow for 24 weeks, yet no significant difference was seen between male groups fed Western diet for 24 weeks (Fig. 3B) . Parallel experiments were conducted in WT and KO female mice. No statistical differences in RER were observed between WT or KO mice at either the 5 or 24-week post-diet time points ( Fig. 3C and Fig. 3D, respectively) .
Hepatotoxicity and lipid accumulation in TRPV1-deficient Mice
In agreement with the gross phenotypic changes related to diet-induced obesity, alterations in liver morphology revealed the deleterious effects of long-term western feeding in both groups. Diet-induced obesity resulted in a marked increase in liver weight in both wild-type and V1KO mice, which was more prominent in male V1KO mice ( Fig. 4A-E) . Paralleling this effect, livers from V1KO mice were paler in color with a considerable increase in size and liver to body weight ratios ( Fig. 4A-D) . Chow-fed V1KO male mice also had larger livers than chow-fed matched WT mice. In female mice of both groups, liver morphology was protected against diet-induced obesity in comparison to male counterparts (Fig 4E-H) . To further assess the effects of dietinduced obesity on liver hepatotoxicity and lipid accumulation, histology was assessed in liver sections using H&E and Oil Red O staining. Oil Red O staining revealed a consistent increase in neutral lipid content of the V1KO livers on both diets, including the control chow. As expected, staining was increased in both wild type and V1KO livers on the chow and western diets, and revealed dramatic neutral lipid accumulation in livers obtained from the V1KO Western-fed diet animals ( Fig. 5A-D ).
Obvious differences were observed between WT and V1K mice on the Western diet using H&E staining. Hepatocyte damage, inflammation or disruption of overall architecture and increased lipid storage were clearly observed ( Fig. 5E-H) . Further evidence of hepatocellular degeneration in livers of wild type and V1KO mice on the western diet was also observed. In striking contrast, the livers of WT mice were mildly affected by western diet, with degeneration of individual hepatocytes along with increases in cell size and intercellular sinusoidal spaces (Fig. 5E-H) . These effects were much more prominent in V1KO mice ( Fig. 5E-H) . Thus, histological analysis confirms the increased toxicity and lipid accumulation as a result of high fat diet consumption in the V1KO mice.
Altered Lipid Homeostasis in TRPV1-Deficient Mice
To further confirm morphological and histological effects on lipid accumulation in the liver, hepatic lipid profiles (cholesterol, triglyceride, and free fatty acid) were examined in each group. The hepatic cholesterol, triglyceride and free fatty acid levels of V1KO mice were all significantly elevated compared to those of WT mice maintained on a chow diet (Fig. 6A, 6C , 6E), consistent with the decreased neutral lipid staining (Fig 5A-D) . In agreement with the enlarged liver mass and distinct color change, hepatic cholesterol was dramatically increased in the western fed wild type and V1KO mice. Consistent with the Oil Red O staining, V1KO mice showed a greater total accumulation of hepatic cholesterol than WT mice on the Western diet (Fig. 3A) . This was similarly accompanied by an increase in triglycerides and hepatic free fatty acid contents for both WT and V1KO mice on the western diet ( Fig. 6C-F) . Increases in triglycerides and hepatic free fatty acid contents following western diet regimen were more pronounced in male V1KO mice compared to WT counterparts. Interestingly, this pronounced increase in lipid content is lost in female V1KO mice on the Western diet, indicating there may be sexspecific differences in cholesterol and lipid homeostasis.
Interestingly, although there were dramatic and differential alterations in hepatic lipid contents in both wild type and V1KO mice following consumption of the different diets, serum cholesterol levels were markedly elevated lipid levels whereas serum TG and FFA levels were relatively unchanged (Fig. 6I ).
Discussion
This study was designed to delineate the mechanisms by which TRPV1 channels regulate hepatic function and lipid metabolism. Our major findings include: 1) V1KO mice are increasingly susceptible to diet-induced obesity compared to WT mice; 2) V1KO mice exhibit severe glucose intolerance due to diet-induced obesity; 3) V1KO mice display augmented liver mass and lipid accumulation compared to WT mice; 4)
Hepatotoxicity in V1KO mice correlates with enhanced levels of hepatic cholesterol, triglycerides, and free fatty acids; 5) Sex differences reveal protective effects against diet-induced obesity and its associated complications in female V1KO mice. This study provides direct evidence that lack of TRPV1 leads to hepatic dysfunction via regulation of liver and serum lipid homeostasis.
Recent evidence indicates that activation of the TRPV1 cation channel by its agonist, capsaicin, is beneficial for the management of obesity, diabetes and related diseases.
As there are no approved therapeutic regimes for treatment of NAFLD, there is a pressing need to search for agents that ameliorate NAFLD phenotypes. A role for TRPV1 in hepatic function has yet to be fully determined, though recent evidence suggests an ability to reduce liver lipid deposition through upregulation of UCP2 (11) and regulate of PPARα-mediated reduction in inflammatory cytokines (10) and PPARδ-dependent autophagy (13) . We initially sought to understand the effects of high fat diet (diet-induced obesity) in wild-type and V1KO mice. In the current study, a 24 week western diet regimen resulted in V1KO mice having increased weight gain over the course of the 24 week period compared to their WT counterparts (Fig. 1) . This is supported by recent findings (14-16), yet contrasts seminal findings which reported that V1KO mice were resistant to diet-induced obesity (17, 18) . A key difference, however, can be attributed to the fat content in the diets used in the current study compared to
Motter and Ahern (42% fat vs. 11% fat respectively). This corresponding enhanced weight gain was also evident in female V1KO mice fed the western diet; yet at the end of the diet regimen, female V1KO mice weighed less than their male counterparts (40.9 ± g vs *35.5 ± g) suggesting females were afforded some degree of protection against diet-induced obesity (Fig. 1B) . Notably, western fed WT female mice did not display significant alterations of body weight when compared to their chow fed counterparts over the course of the 24-week period. These findings, although paradoxical, are consistent with previous investigations (19) (20) (21) suggesting that particular strains of female mice may be protected from diet-induced obesity.
A role for TRPV1 in the regulation of adipocytes has been previously described (22) (23) (24) .
Additionally, our data and others (14) support the notion that the loss of TRPV1 and resulting susceptibility to diet-induced obesity leads to a further diminished "lean mass:body weight ratio" and enhanced whole body fat mass (as measured by EchoMRI) in V1KO mice fed the western diet (Fig. 1B and 1C ) compared to WT counterparts.
While it is largely accepted that TRPV1 contributes to overall metabolic homeostasis via roles in thermogenesis, regulation of adipogenesis, satiety and energy expenditure (7, 25) , it is increasingly apparent that the role of TRPV1 is much more complex. For instance, TRPV1 signaling has been implicated in enhancing fat accumulation to thus modulate energy and glucose homeostasis (26) . In this regard, TRPV1 has been shown to influence glucagon-like peptide-1 (GLP-1) secretion (27) , adipogenesis (23) , and innervation of the liver to regulate glucose handling (28) . Furthermore, previous investigations reported that elimination of capsaicin-sensitive fibers in Zucker diabetic fatty rats led to improved glucose tolerance and insulin resistance (29) . Complementary experiments illustrated the ability of TRPV1 antagonism to reverse the elevated glucose and insulin levels and improve glucose tolerance in a diabetic mouse model (30) .
TRPV1 has also been linked to insulin secretion regulation and islet inflammation through pancreatic islets innervation (31) . However, the uncertainty surrounding the ability of TRPV1 to regulate insulin and glucose handling needs further investigation. A large body of evidence supports a complex interaction between NAFLD and insulin resistance (32, 33) . Our current findings further substantiate the role for TRPV1 in glucose handling and insulin sensitivity as our data indicates an increased fasting glucose level and glucose intolerance following the high-fat diet regimen in V1KO mice compared to high-fat diet fed WT mice. Importantly, while both of these parameters are increased in the high-fat diet fed wild-type mice, the effects are further amplified by the absence of TRPV1. Female mice fed a chow diet are not glucose intolerant, regardless of genotypic background. The differences in these observations between sexes indicate that female V1KO mice are comparable to wild-type mice on a normal diet, while male V1KO mice are pre-dispositioned to dysfunction without Western diet.
Recent research has begun to elucidate the mechanisms that govern TRPV1-dependent hepatic regulation of lipid homeostasis. For instance, a role for TRPV1-mediated increases in hepatic UCP2 expression has been demonstrated, which may account for decreased fatty deposition following a high fat diet (11) . Additional investigations also demonstrated a role for attenuated NAFLD via enhanced PPARδ-mediated autophagy enhancement (13) . In the current study, western diet fed WT and V1KO mice exhibited significant increases in liver weights and lipid accumulation.
Furthermore, Western diet resulted in augmentation in liver size in both WT and V1KO mice, although the severity of these symptoms was more developed in the V1KO mice.
We next examined the cellular indices of NAFLD using Oil Red O staining. As expected from the gross liver morphology, lipid accumulation was particularly dramatic in the V1KO Western-fed livers (Fig. 5A-D) . Lipid drop accumulation as seen by increased adipocyte number and size were evident in V1KO animals. Importantly, these are key characteristics attributed to NAFLD.
Similar observations were made in both WT and V1KO animals with H&E staining;
hepatocyte damage and degeneration, increased intercellular sinusoidal spaces, inflammation, increased lipid droplet size and number and disruption of overall architecture was clearly evident (Fig. 5E-H) . The severity of these changes were strikingly more evident in V1KO mice fed the western diet, confirming a role for TRPV1
in diet-induced hepatotoxicity and lipid accumulation.
To correlate the increase in lipid accumulation observed using Oil Red O staining, we next examined liver lipid content in respect to whole liver cholesterol, triglyceride and free fatty acid levels. 24 weeks of Western diet resulted in higher total hepatocyte cholesterol, triglyceride and free fatty acid levels in both WT and V1KO mice, however, this effect was magnified in V1KO mice, leading to significant differences between groups. While Western diet increased whole liver cholesterol, triglyceride and free fatty acid levels in females, there was no measurable difference between genotypes. In addition, similar measurements taken from serum revealed different trends than that of the liver. The effects of genotype, sex, or diet elicited no impact on serum triglyceride and free fatty acid levels.
Conclusions
In conclusion, the current data demonstrates a role for TRPV1 in diet-induced obesity and subsequent induction of NAFLD. Western fed V1KO mice, when compared to their WT counterparts, demonstrate various pathophysiological disturbances including glucose intolerance and exacerbated progression of diet-induced obesity, as well as altered lipid profiles and gross morphological alterations in liver composition and size.
Furthermore, there appears to be a sex-specific component whereby female V1KO mice were resistant to diet-induced obesity and the progression of NAFLD when compared to the male mice. Therefore, it is evident that the activation of TRPV1 may lead to improved hepatic health and prevention of NAFLD, yet the need to explore the role of TRPV1 in the liver and its contribution to the onset and development of NAFLD continues to grow. 
